-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Kalaris Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q1 2021 to Q3 2025.
- Kalaris Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2025 was -63.6 %, a 12.4% increase year-over-year.
- Kalaris Therapeutics, Inc. annual Return On Assets for 2024 was -58.2 %, a 26.2% increase from 2023.
- Kalaris Therapeutics, Inc. annual Return On Assets for 2023 was -78.9 %, a 17.1% decline from 2022.
- Kalaris Therapeutics, Inc. annual Return On Assets for 2022 was -67.4 %, a 25.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)